Zurich, Switzerland

Thomas Ortner

This inventor holds 1 USPTO granted patent. Top assignee: International Business Machines Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Ortner. Retrieved from https://idiyas.com/inventor/thomas-ortner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Ortner: Inventor in Artificial Neural Networks.

Introduction

Thomas Ortner is an inventor based in Zurich, Switzerland. His patent work concerns methods for modulating neuronal activity in artificial neural networks. He is associated with International Business Machines Corporation.

Latest Patents

Ortner is credited with 1 patent: “Neuronal Activity Modulation of Artificial Neural Networks.” The invention describes an artificial neural network with base neuron populations that produce an inferencing result during training or inference. A separate control neuron population can modulate the activity of one or more base populations by scaling operands those populations produce internally.

Career Highlights

Ortner’s listed patent reflects work on neural-network architecture and the control of neuronal activity. The disclosed approach uses a distinct control population to influence the operation of base neuron populations.

Collaborations

Ortner’s listed coworker is Ayush Garg. His patent is associated with International Business Machines Corporation.

Conclusion

Thomas Ortner’s patent focuses on a control mechanism for modulating activity within artificial neural networks, highlighting his contribution to innovation in machine learning systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…